Sorrento Therapeutics, Inc. (SRNE)

Trade SRNE now with
1/20/2022 9:03:19 AM Sorrento Therapeutics Announces Covishield Potently Neutralizes Omicron And Omicron Variants Of Sars-Cov-2
4/5/2021 9:07:36 AM Sorrento Therapeutics To Acquire ACEA Therapeutics
1/26/2021 7:42:56 PM Sorrento Reports Positive Preliminary Results Of Phase 1b Study Of COVI-MSC For Treatment Of ICU COVID-19 Patients
12/22/2015 8:34:03 AM FBR Capital Markets Initiates Sorrento Therapeutics, Inc. (SRNE) At Outperform With $22 Price Target